These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 4582147

  • 1. Spironolactone and frusemide in cirrhosis with ascites.
    Sadikali F.
    Br J Clin Pract; 1973 Jun; 27(6):222-4. PubMed ID: 4582147
    [No Abstract] [Full Text] [Related]

  • 2. Attenuation by spironolactone of the magnesiuric effect of acute frusemide administration in patients with liver cirrhosis and ascites.
    Stergiou GS, Mayopoulou-Symvoulidou D, Mountokalakis TD.
    Miner Electrolyte Metab; 1993 Jun; 19(2):86-90. PubMed ID: 8377729
    [Abstract] [Full Text] [Related]

  • 3. High doses of spironolactone (Aldactone, SC-14266, Verospirone) alone and in combination with triamterene and-or diuretics in the treatment of refractory edema associated with secondary hyperaldosteronism.
    Radó JP, Marosi J, Takó J.
    Endokrinologie; 1970 Jun; 57(1):46-62. PubMed ID: 4923990
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of azosemide and furosemide in ascitic patients without and during administration of spironolactone.
    Radó JP, Molnár Z, Hartai A, Gercsák G.
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):532-7. PubMed ID: 7174156
    [Abstract] [Full Text] [Related]

  • 5. [Diuretic treatment and metabolic alkalosis in ascitic liver cirrhosis].
    Grassi V, Porcellati C, Corea L, Todisco T.
    Minerva Nefrol; 1968 Nov; 15(4):258-60. PubMed ID: 5745815
    [No Abstract] [Full Text] [Related]

  • 6. [Rational use of diuretics in hepatic cirrhosis].
    Vagge R, Cavatorta F, Queirolo C.
    G Clin Med; 1983 Nov; 64(3-4):116-23. PubMed ID: 6884638
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical evaluation of the use of diuretics in the ascitic phase of hepatic cirrhosis].
    Castagnolo B, De Colibus V, Napolitano L, Aliperta A, Caldarelli G, Abignente F.
    Clin Ter; 1977 Dec 31; 83(6):625-9. PubMed ID: 343976
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of ascites in hepatic cirrhosis].
    Arroyo JL, Bueno J, Rivero A, Lucas I, Ortiz de Landazuri E.
    Rev Esp Enferm Apar Dig; 1966 Nov 31; 25(9):1021-46. PubMed ID: 5997895
    [No Abstract] [Full Text] [Related]

  • 9. Comparative efficacy of spironolactone and hydrochlorothiazide (separately and in combination) in cirrhotic edema.
    Munshi CP, Sawkar LA, Vaidya PM, Gulati OD.
    J Assoc Physicians India; 1967 Dec 31; 15(12):583-9. PubMed ID: 4870785
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of diuretics in the treatment of cirrhotic ascites.
    Boyer TD, Warnock DG.
    Gastroenterology; 1983 May 31; 84(5 Pt 1):1051-5. PubMed ID: 6832557
    [No Abstract] [Full Text] [Related]

  • 12. [Effect of aldactone on potassium storage in patients with ascitic cirrhosis].
    Lévy VG, Lassale B, Del Corso A, Caroli J.
    Ann Med Interne (Paris); 1970 Feb 31; 121(2):183-90. PubMed ID: 5491199
    [No Abstract] [Full Text] [Related]

  • 13. Diuresis in the ascitic patient: a randomized controlled trial of three regimens.
    Fogel MR, Sawhney VK, Neal EA, Miller RG, Knauer CM, Gregory PB.
    J Clin Gastroenterol; 1981 Feb 31; 3 Suppl 1():73-80. PubMed ID: 7035545
    [Abstract] [Full Text] [Related]

  • 14. [Amiloride. A clinical study of a potassium-retaining diuretic].
    Juul J.
    Ugeskr Laeger; 1969 Oct 16; 131(42):1785-90. PubMed ID: 4914022
    [No Abstract] [Full Text] [Related]

  • 15. [Controlled study of the effect of long-term administration of canrenoate potassium in cirrhotic ascites].
    Traina M, Vizzini GB.
    Minerva Med; 1986 Jan 28; 77(3-4):87-91. PubMed ID: 3511409
    [Abstract] [Full Text] [Related]

  • 16. [Experience in the treatment of water-salt retentions in cirrhosis by the antialdosterone 11614 R.P].
    Boivin P, Fauvert R.
    Rev Int Hepatol; 1969 Jan 28; 19(4):241-51. PubMed ID: 5404532
    [No Abstract] [Full Text] [Related]

  • 17. [Pathogenesis and therapy of ascites in liver cirrhosis].
    Dölle W.
    Internist (Berl); 1966 Jan 28; 7(1):48-54. PubMed ID: 4861685
    [No Abstract] [Full Text] [Related]

  • 18. The diuretic effect of muzolimine (Bay g 2821) on hepatogenic ascites.
    Heinrich F, Loew D, Dýcka J.
    Curr Med Res Opin; 1966 Jan 28; 4(10):706-15. PubMed ID: 800972
    [Abstract] [Full Text] [Related]

  • 19. Potassium and magnesium depletion in patients with cirrhosis on maintenance diuretic regimens.
    Wheeler PG, Smith T, Golindano C, Alam AN, Wilkinson SP, Edmonds CJ, Williams R.
    Gut; 1977 Sep 28; 18(9):683-7. PubMed ID: 604188
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.